Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Low Bladder Compliance
NCT05745584Unknown
- Sponsor
- Yonsei University
- Start
- Jan 2016
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mirabegron in neurogenic bladder, sponsored by Yonsei University. Primary endpoint: Change in Bladder compliance at 8 weeks. Status: unknown.
02
Drugs
mirabegron
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT05745584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745584.